Mechanisms of toxification and detoxification which challenge drug candidates and drugs

Comprehensive Medicinal Chemistry II

Volumn 5, Issue , 2006, Pages 193-214

  Oesch Bartlomowicz, B ^a   Oesch, F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906428924     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Oesch, E; Arand, M. Xenobiotic Metabolism. In Toxicology; Marquardt, H., Schäfer, S. G., McClellan, R., Welsch, E, Eds.; Academic Press: New York, 1999, pp 83-109.
2. Testa, B. The Metabolism of Drugs and Other Xenobiotics-Biochemistry of Redox Reactions', Academic Press: London, UK, 1995.
3. Testa, B.; Mayer, J. M. Hydrolysis in Drug and Prodrug Metabolism. Chemistry, Biochemistry and Enzymology'; Verlag Helvetica Chimica Acta: Zurich, Switzerland, 2003.
4. Nelson, D. R.; Koymans, L.; Kamataki, T; Stegeman, J. J.; Eeyereisen, R.; Waxman, D. J.; Waterman, M. R.; Gotoh, O.; Coon, M. J.; Estabrook, R. W et al. Pharmacogenetics 1996, 6, 1-42.
5. Estabrook, R. W FASEB J. 1996, 10, 202-204.
6. Guengerich, E P. Chem. Res. Toxicol. 2001, 14, 611-650.
7. Gonzalez, E J.; Lee, Y H. FASEBJ. 1996, 10, 1112-1117.
8. Nebert, D. W; McKinnon, R. A. Prog. Liver Dis. 1994, 12, 63-97.
9. Coon, M. J.; Vaz, A. D. N.; Bestervelt, L. L. FASEB J. 1996, 10, 428-434.
10. Zangar, R. C.; Davydov, D. R.; Verma, S. Toxicol. Appl. Pharmacol. 2004, 199, 316-331.
11. Ioannides, C.; Lewis, D. F Curr. Top. Med. Chem. 2004, 4, 1767-1788.
12. Gonzalez, F J.; Gelboin, H. V DrugMetab. Rev. 1994, 26, 165-183.
13. Kawajiri, K.; Hayashi, S. I. The CYP1 Family. In Cytochromes P450-Metabolic and ToxicologicalAspects; Ioannides, C., Ed.; CRC Press: Boca Raton, USA, 1996, pp 77-97.
14. Fernandez-Salguero, P. M.; Gonzalez, F J. Targeted Disruption of Specific Cytochromes P450 and Xenobiotic Receptor Genes. In Cytochrome P450; Johnson, E. F, Waterman, M. R., Eds.; Academic Press: San Diego, CA, 1996; Vol. 272, pp 412-430.
15. Conney, A. H.; Chang, R. L.; Cui, X. X.; Schiltz, M.; Yagi, H.; Jerina, D. M.; Wie, S. J. Adv. Exp. Med. Biol. 2001, 500, 697-707.
16. Oesch, F Arch. Toxicol. 1979, Suppl. 2, 215-227.
17. Sogawa, K.; Matsushita, N.; Ema, M.; Fujii-Kuriyama, Y DNA-Binding Regulatory Factors and Inducible Expression of the P4501A1 Gene. In Cytochrome P450; Lechner, M. C., Ed.; John Libbey Eurotext Ltd: Montrouge, France, 1994, pp 75-80.
18. Whitlock, J. P; Okino, S. T; Dong, L. Q.; Ko, H. S. P.; Clarke-Katzenberg, R.; Qiang, M.; Li, H. FASEB J. 1996, 10, 809-818.
19. Oesch-Bartlomowicz, B.; Huelster, A.; Wiss, O.; Antoniou-Lipfert, P.; Dietrich, C.; Arand, M.; Weiss, C.; Bockamp, E.; Oesch, F Proc. Natl. Acad. Sei. USA 2005, 102, 9218-9223.
20. Raunio, H.; Rautio, A.; Pelkonen, O. IARC Sei. Publ. 1999, 148, 197-207.
21. Gervot, L.; Rochat, B.; Gautier, J. C.; Bohnenstengel, F; Kroemer, H.; de Berardinis, V; Martin, H.; Beaune, P; de Waziers, I. Pharmacogenetics 1999, 9, 295-306.
22. Huang, Z.; Waxman, D. J. Cancer Gene Ther. 2001, 8, 450-458.
23. Oesch-Bartlomowicz, B.; Richter, B.; Becker, R.; Vogel, S.; Padma, P. R.; Hengstler, J. G.; Oesch, F Int. J. Cancer 2001, 94, 733-742.
24. Goldstein, J. A.; de Morais, S. M. F. Pharmacogenetics 1994, 4, 285-299.
25. Eichelbaum, M.; Ingelman-Sundberg, M.; Evans, W E. Annu. Rev. Med. 2006, 57, 119-137.
26. Yu, A. M.; Idle, J. R.; Gonzalez, F J. DrugMetab. Rev. 2004, 36, 243-277.
27. Kessova, I.; Cederbaum, A. I. Curr. Mol. Med. 2003, 3, 509-518.
28. Ronis, M. J. J.; Lindros, K. O.; Ingelman-Sundberg, M. The CYP2E Family. In Cytochromes P450-Metabolic and Toxicological Aspects; Ioannides, C., Ed.; CRC Press: Boca Raton, FL, 1996, pp 211-239.
29. Oesch-Bartlomowicz, B.; Padma, P. R.; Becker, R.; Richter, B.; Hengstler, J. G.; Freeman, J. E.; Wolf, C. R.; Oesch, F Exp. Cell Res. 1998, 242, 294-302.
30. Maurel, P The CYP3 Family. In Cytochromes P450-Metabolic and Toxicological Aspects; Ioannides, C., Ed.; CRC Press: Boca Raton, FL, 1996, pp 241-270.
31. Cashman, J. R. Chem. Res. Toxicol. 1995, 8, 165-181.
32. Jörnvall, H.; Höög, J. Alcohol Alcoholism 1995, 30, 153-161.
33. Glatt, H. R.; Vogel, K.; Bentley, P; Oesch, F Nature 1979, 277, 319-320.
34. Glatt, H. R.; Cooper, C. S.; Grover, P. L.; Sims, P.; Bentley, P; Merdes, M.; Waechter, Fi; Vogel, K.; Guenthner, T M.; Oesch, F Science 1982, 215, 1507-1509.
35. Wörner, W; Oesch, F FEBS Lett. 1984, 170, 263-267.
36. Maser, E.; Richter, E.; Friebertshauser, J. Eur. J. Biochem. 1996, 238, 484-489.
37. Wermuth, B.; Platt, K. L.; Seidel, A.; Oesch, Fi Biochem. Pharmacol. 1986, 35, 1277-1282.
38. Arand, M.; Oesch, F Mammalian Xenobiotic Epoxide Hydrolases. In Handbook of Enzyme Systems that Metabolize Drugs and Other Xenobiotics; Ioannides, C., Ed.; John Wiley: Chichester, UK, 2002, pp 459-483.
39. Oesch, F. Biochem. J. 1974, 139, 77-88.
40. Oesch, F; Bentley, P. Nature 1976, 259, 53-55.
41. Guenthner, T M.; Hammock, B. D.; Vogel, U.; Oesch, F J. Biol. Chem. 1981, 256, 3163-3166.
42. Morisseau, C.; Hammock, B. D. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 311-333.
43. Arand, M.; Grant, D. F; Beetham, J. K.; Friedberg, T; Oesch, F; Hammock, B. D. FEBS Lett. 1994, 338, 251-256.
44. Armstrong, R. N. CRC Crit. Rev. Biochem. 1987, 22, 39-88.
45. Arand, M.; Wagner, H.; Oesch, F J. Biol. Chem. 1996, 271, 4223-4229.
46. Oesch, F; Herrero, M. E.; Hengstler, J. G.; Lohmann, M.; Arand, M. Toxicol. Pathol. 2000, 28, 382-387.
47. Herrero, M. E.; Arand, M.; Hengstler, J. G.; Oesch, F Environ. Mol. Mutagen 1997, 30, 429-439.
48. Armstrong, R. N. Chem. Res. Toxicol. 1991, 4, 131-140.
49. Glatt, H.; Protic-Sabljic, M.; Oesch, F Science 1983, 220, 961-963.
50. Dekant, W; Vamvakas, S. Crit. Rev. Toxicol. 1996, 26, 309-334.
51. Chen, H. W; Sandler, D. P.; Taylor, J. A.; Shore, D. L.; Liu, E.; Bloomfield, C. D.; Bell, D. A. Lancet 1996, 347, 295-297.
52. Burchell, B.; McGurk, K.; Brierley, C. H.; Clarke, D. J. UDP-Glucuronosyltransferases. In Comprehensive Toxicology; Guengerich, F P., Ed.; Elsevier: Amsterdam, Netherlands, 1997; Vol. 3, pp 401-435.
53. Bock, K. W. Crit. Rev. Biochem. Mol. Biol. 1991, 26, 129-150.
54. Owens, I. S.; Ritter, J. K. Gene Structure at the Human UGT1 Locus Creates Diversity in Isozyme Structure, Substrate Specificity and Regulation. In Progress in Nucleic Acid Research and Molecular Biology; Cohn, W E., Moldave, K., Eds.; Academic Press: San Diego, CA, 1995; Vol. 51, pp 305-338.
55. Glatt, H. R. Sulphotransferases. In Handbook of Enzyme Systems that Metabolise Drugs and Other Xenobiotics; Ioannides, C., Ed.; John Wiley: Chichester, UK, 2002, pp 353-439.
56. Coughtrie, M. W H. Hum. Exp. Toxicol. 1996, 15, 547-555.
57. Goodfellow, G. H.; Dupret, J. M.; Grant, D. M. Biochem J 2000, 348, 159-166.
58. Badawi, A. F; Stern, S. J.; Lang, N. P.; Kadlubar, F F Prog. Clin. Biol. Res. 1996, 395, 109-140.
59. Vistisen, K.; Poulsen, H. E.; Loft, S. Carcinogenesis 1992, 13, 1561-1568.
60. Morgan, E. T; Thomas, K. B.; Swanson, R.; Vales, T; Hwang, J.; Wright, K. Biochim. Biophys. Acta 1994, 1219, 475-483.
61. Nebert, D. W; McKinnon, R. A.; Puga, A. DNA Cell Biol. 1996, 15, 273-280.
62. Smith, C. A. D.; Smith, G.; Wolf, C. R. Eur. J. Cancer 1994, 30A, 1921-1935.
63. Meyer, U. A.; Zanger, U. M. Annu. Rev. Pharmacol. Toxicol. 1997, 37, 269-296.
64. Hengstler, J. G.; Arand, M.; Herrero, M. E.; Oesch, E Recent Results Cancer Res. 1998, 154, 47-85.
65. Ingelman-Sundberg, M. Toxicology 2002, 181-182, 447-452.
66. Brockmöller, J.; Cascorbi, I.; Kerb, R.; Roots, I. Cancer Res. 1996, 56, 3915-3925.
67. Wormhoudt, L. W; Commandeur, J. N.; Vermeulen, N. P. Crit. Rev. Toxicol. 1999, 29, 59-124.
68. Hengstler, J. G.; Oesch, E. Interspecies Differences in Xenobiotic Metabolizing Enzymes and their Importance for Interspecies Extrapolation of Toxicity. In General and Applied Toxicology; Ballantyne, B., Marrs, T C., Syversen, T, Eds.; Macmillan: London, 1999, pp 271-290.
69. Turesky, R. J. Mol. Nutr. Food Res. 2005, 49, 101-117.
70. Utesch, D.; Glatt, H.; Oesch, E Cancer Res. 1987, 47, 1509-1515.
71. Hengstler, J. G.; Utesch, D.; Steinberg, P.; Platt, K. L.; Diener, M.; Ringel, M.; Swales, N.; Eischer, T; Biefang, K.; Gerl, M.et al. Drug Metab. Rev. 2000, 32, 81-118.
72. Gonzalez, E J.; Yu, A. M. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 41-64.
73. Buening, M. K.; Wislocki, P G.; Levin, W; Yagi, H.; Thakker, D. R.; Akagi, H.; Koreeda, M.; Jerina, D. M.; Conney, A. H. Proc. Natl. Acad. Sci. USA 1978, 75, 5358-5361.